User profiles for Michael Lundemann

Michael Lundemann

Radiobotics
Verified email at radiobotics.com
Cited by 820

Cardiovascular disease after treatment for Hodgkin's lymphoma: an analysis of nine collaborative EORTC-LYSA trials

…, F Giusti, IR Vogelius, M Lundemann… - The Lancet …, 2015 - thelancet.com
Background Cardiovascular disease after treatment is an important concern in cancer
survivors. However, knowledge of cardiotoxicity is limited by the retrospective nature of data, …

Minimizing late effects for patients with mediastinal Hodgkin lymphoma: deep inspiration breath-hold, IMRT, or both?

…, MV Maraldo, DA Schut, M Lundemann… - International Journal of …, 2015 - Elsevier
Purpose Hodgkin lymphoma (HL) survivors have an increased risk of cardiovascular disease
(CD), lung cancer, and breast cancer. We investigated the risk for the development of CD …

Feasibility of multi-parametric PET and MRI for prediction of tumour recurrence in patients with glioblastoma

M Lundemann, P Munck af Rosenschöld… - European journal of …, 2019 - Springer
Background Recurrence in glioblastoma patients often occur close to the original tumour and
indicates that the current treatment is inadequate for local tumour control. In this study, we …

Impact of [18F]-fluoro-ethyl-tyrosine PET imaging on target definition for radiation therapy of high-grade glioma

…, J Costa, SA Engelholm, MJ Lundemann… - Neuro …, 2015 - academic.oup.com
Background We sought to assess the impact of amino-acid 18 F-fluoro-ethyl-tyrosine (FET)
positron emission tomography (PET) on the volumetric target definition for radiation therapy …

[HTML][HTML] Clinical PET/MRI in neurooncology: opportunities and challenges from a single-institution perspective

L Marner, OM Henriksen, M Lundemann… - Clinical and translational …, 2017 - Springer
Purpose Magnetic resonance imaging (MRI) plays a key role in neurooncology, ie, for
diagnosis, treatment evaluation and detection of recurrence. However, standard MRI cannot …

[HTML][HTML] A modality-adaptive method for segmenting brain tumors and organs-at-risk in radiation therapy planning

…, PM af Rosenschöld, O Puonti, MJ Lundemann… - Medical image …, 2019 - Elsevier
In this paper we present a method for simultaneously segmenting brain tumors and an
extensive set of organs-at-risk for radiation therapy planning of glioblastomas. The method …

[HTML][HTML] External validation of an artificial intelligence tool for radiographic knee osteoarthritis severity classification

…, A Lenskjold, M Axelsen, M Lundemann… - European Journal of …, 2022 - Elsevier
… Martin Axelsen and Michael Lundemann are employees of Radiobotics ApS. Mikael Ploug
Boesen is part of the medical advisory board at Radiobotics ApS and holds parts in the …

Early postoperative 18F-FET PET/MRI for pediatric brain and spinal cord tumors

…, OM Henriksen, M Lundemann… - Journal of Nuclear …, 2019 - Soc Nuclear Med
Complete resection is the treatment of choice for most pediatric brain tumors, but early
postoperative MRI for detection of residual tumor may be misleading because of MRI signal …

Diagnostic accuracy and clinical impact of [18F]FET PET in childhood CNS tumors

L Marner, M Lundemann, A Sehested, K Nysom… - Neuro …, 2021 - academic.oup.com
Background Central nervous system (CNS) tumors cause the highest death rates among
childhood cancers, and survivors frequently have severe late effects. Magnetic resonance …

A framework for voxel‐based assessment of biological effect after proton radiotherapy in pediatric brain cancer patients using multi‐modal imaging

M Skaarup, MJ Lundemann, S Darkner… - Medical …, 2021 - Wiley Online Library
Introduction The exact dependence of biological effect on dose and linear energy transfer (LET)
in human tissue when delivering proton therapy is unknown. In this study, we propose a …